We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Throughout the year, you will have the opportunity to participate in campaigns that support endocrinology research, care, professionals, and patients. Contact us to get more involved: [email protected].
Taking action by sending messages to your Congressional delegation makes a difference, and our online campaigns make it easy to do. Don't take it from us, hear from Rosa DeLauro, Ranking Member of the House Appropriations Committee, why your voice matters.
Funding for SDP is set to expire on January 30, 2026, unless Congress passes legislation to extend the program. Join the Endocrine Society in urging Congress to pass a long-term reauthorization of SDP. It is critical that members of Congress hear from you, the constituent, about the importance of this life-saving program.
Congress failed to pass legislation extending Medicare telehealth flexibilities, which ensures that Medicare beneficiaries can receive care via telehealth from home. This has resulted in an abrupt end to telehealth services for millions of Medicare beneficiaries. Access to telehealth services serves as a lifeline to millions across the country, particularly for individuals with complex chronic conditions including diabetes and obesity. The Endocrine Society members are encouraged to take action to urge Congress to immediately pass a long-term telehealth fix.
We need Members of Congress to cosponsor the Treat and Reduce Obesity Act (TROA). This legislation would allow coverage of anti-obesity medications (AOMs) currently prohibited in the Medicare statute and expand access to intensive behavioral therapy (IBT) for obesity. It is critical that your Senators and Representatives hear from you on the importance of cosponsoring this legislation. Endocrine Society members are encouraged to take action to share the importance of cosponsoring this legislation.
We need Congress to negotiate full-year funding that protects funding for the National Institutes of Health (NIH) for Fiscal Year 2026. The current Continuing Resolution fails to provide needed increases to research funding and does not include necessary provisions to prevent administrative interference in grant awards. Now is the time to contact all Representatives and Senators to advocate for research funding.
Since January, there have been multiple actions to cut federal funding of research including attempts to freeze all grants and limit indirect costs for NIH grants to 15%. These efforts have caused major harm to institution budgets, jeopardized lifesaving medical research, caused layoffs, suspended clinical trials, and disrupted ongoing research and laboratory support programs. While federal judges have blocked these actions at least temporarily, we are concerned there will be further efforts to cut federal funding of research. Endocrine Society members are encouraged to join our campaign to share with your US Representative and Senators how cutting federal funding for your research would impact your work.
Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.
